1. Home
  2. BHVN vs TMDX Comparison

BHVN vs TMDX Comparison

Compare BHVN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$13.75

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

N/A

Current Price

$92.11

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BHVN
TMDX
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
BHVN
TMDX
Price
$13.75
$92.11
Analyst Decision
Buy
Buy
Analyst Count
17
13
Target Price
$23.73
★ $104.55
AVG Volume (30 Days)
★ 3.0M
1.1M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
26.08
★ 382.18
EPS
N/A
★ 1.08
Revenue
N/A
★ $605,494,000.00
Revenue This Year
N/A
$26.70
Revenue Next Year
N/A
$17.50
P/E Ratio
★ N/A
$85.37
Revenue Growth
N/A
★ 37.13
52 Week Low
$7.99
$60.11
52 Week High
$18.24
$156.00

Technical Indicators

Market Signals
Indicator
BHVN
TMDX
Relative Strength Index (RSI) 47.39 67.27
Support Level $13.56 $65.51
Resistance Level $15.27 $92.93
Average True Range (ATR) 1.00 4.94
MACD -0.12 3.05
Stochastic Oscillator 12.82 84.04

Price Performance

Historical Comparison
BHVN
TMDX

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: